Pharmacogenomics: Global Market Opportunities by Technology,

Dublin, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market Size, Share, Trends, Opportunity, and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The global pharmacogenomics market is poised for robust growth during the forecast period, driven by the increasing adoption of personalized medicine in healthcare. The rising prevalence of chronic diseases, such as cancer, cardiovascular ailments, respiratory disorders, and renal conditions, has escalate

Related Keywords

California , United States , Dublin , Ireland , Israel , American , America , Pacific Biosciences , Asia Pacific , Research Development Activities , Admera Health , Research Methodology , Illumina Inc , California Inc , Israel Precision Medicine Partnership , Oxford Nanopore Technologies , Infosys , Perkinelmer Inc , Agilent Technologies Inc , Abbott Laboratories Inc , Genetics Inc , Thermo Fischer Scientific Inc , National Institute Of Health , Bio Rad Laboratories Inc , Pharmacogenomics Market Size , Infosys Limited , Adverse Drug Reactions , National Institute , North America , Fischer Scientific , Rad Laboratories , South America , Middle East , North American , Global Pharmacogenomics , Pharmacogenomics Market , America Pharmacogenomics Market , Pacific Pharmacogenomics Market , Africa Pharmacogenomics Market , Personalized Medicine , Pharmaceutical Industry , Research And Development , Robust Growth , Chronic Diseases , Pharmacogenomics , Clinical Trials , Market Segmentation ,